IRIS
CAPURSO, GABRIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.204
EU - Europa 8.554
AS - Asia 8.072
SA - Sud America 1.536
Continente sconosciuto - Info sul continente non disponibili 618
AF - Africa 135
OC - Oceania 9
Totale 28.128
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.577
RU - Federazione Russa 4.842
SG - Singapore 3.090
CN - Cina 2.499
IT - Italia 1.677
BR - Brasile 1.263
HK - Hong Kong 938
VN - Vietnam 615
FR - Francia 409
SE - Svezia 376
DE - Germania 306
BD - Bangladesh 294
CA - Canada 294
GB - Regno Unito 270
IN - India 126
FI - Finlandia 121
AR - Argentina 106
MX - Messico 106
NL - Olanda 104
PL - Polonia 84
AT - Austria 80
ZA - Sudafrica 65
TR - Turchia 64
ES - Italia 60
JP - Giappone 60
IQ - Iraq 54
ID - Indonesia 52
CR - Costa Rica 51
EC - Ecuador 45
JM - Giamaica 39
IE - Irlanda 33
MD - Moldavia 33
PK - Pakistan 30
UA - Ucraina 29
VE - Venezuela 29
UZ - Uzbekistan 28
LT - Lituania 26
CO - Colombia 25
HN - Honduras 24
RO - Romania 23
GT - Guatemala 22
MY - Malesia 21
PH - Filippine 21
TT - Trinidad e Tobago 20
AE - Emirati Arabi Uniti 19
BE - Belgio 19
PY - Paraguay 19
SA - Arabia Saudita 19
NI - Nicaragua 18
SV - El Salvador 18
IL - Israele 17
NP - Nepal 15
UY - Uruguay 14
CL - Cile 13
JO - Giordania 13
MA - Marocco 13
BH - Bahrain 12
CW - ???statistics.table.value.countryCode.CW??? 11
KE - Kenya 11
TW - Taiwan 11
CH - Svizzera 10
PR - Porto Rico 10
TH - Thailandia 10
AU - Australia 9
EG - Egitto 9
OM - Oman 9
PT - Portogallo 9
TN - Tunisia 9
IR - Iran 8
PE - Perù 8
BO - Bolivia 7
EE - Estonia 7
CZ - Repubblica Ceca 6
DZ - Algeria 6
AL - Albania 5
GP - Guadalupe 5
HU - Ungheria 5
KR - Corea 5
LB - Libano 5
PS - Palestinian Territory 5
AM - Armenia 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
GE - Georgia 4
GY - Guiana 4
KZ - Kazakistan 4
AZ - Azerbaigian 3
CI - Costa d'Avorio 3
CY - Cipro 3
ET - Etiopia 3
GR - Grecia 3
HR - Croazia 3
KW - Kuwait 3
PA - Panama 3
SR - Suriname 3
VC - Saint Vincent e Grenadine 3
AO - Angola 2
BG - Bulgaria 2
BS - Bahamas 2
BY - Bielorussia 2
Totale 27.482
Salva come PNG Salva come JPEG
Città #
Singapore 1.538
Ashburn 1.338
San Jose 1.119
Moscow 1.033
Dallas 972
Hong Kong 922
Council Bluffs 455
Shanghai 452
Milan 420
Hefei 349
Beijing 307
Lauterbourg 302
New York 262
Phoenix 225
Ho Chi Minh City 215
Santa Clara 190
Los Angeles 189
Hanoi 148
Rome 134
São Paulo 130
Nuremberg 94
Princeton 91
Boardman 87
Munich 87
Lawrence 86
Orem 82
Montreal 77
Warsaw 69
Brooklyn 68
Atlanta 64
Chicago 63
Miano 63
North Bergen 58
Tokyo 51
Johannesburg 49
Rio de Janeiro 48
Turku 48
Helsinki 47
Toronto 47
Naples 44
Washington 44
Denver 42
London 42
Stockholm 42
Buffalo 41
Guangzhou 41
Houston 41
Chennai 39
Vienna 39
Frankfurt am Main 38
Mexico City 36
Seattle 36
Amsterdam 35
Bologna 35
Las Vegas 35
Manchester 35
Poplar 33
San José 33
Boston 32
Dublin 31
Brescia 30
Brasília 28
Miami 28
Belo Horizonte 26
Lappeenranta 26
Da Nang 25
Tashkent 25
Philadelphia 24
Ankara 23
Columbus 23
San Francisco 23
Cesano Boscone 21
Curitiba 21
Kingston 21
Omaha 21
Palermo 21
Barnet 20
Mumbai 20
Shenzhen 20
The Dalles 20
Jacksonville 19
Assago 18
Hangzhou 18
Majano 18
Managua 18
Paris 18
Campinas 17
Haiphong 17
Minneapolis 17
Porto Alegre 17
Charlotte 16
Florence 16
San Salvador 16
Tianjin 16
Cleveland 15
Dhaka 15
Newark 15
Salvador 15
The Bronx 15
Verona 15
Totale 13.570
Salva come PNG Salva come JPEG
Nome #
Endoscopic ultrasound-guided choledochoduodenostomy versus hepaticogastrostomy combined with gastroenterostomy in malignant double obstruction (CABRIOLET_Pro): A prospective comparative study 212
Impact of age, comorbidities and relevant changes on surveillance strategy of intraductal papillary mucinous neoplasms: A competing risk analysis 208
European evidence-based guidelines on pancreatic cystic neoplasms 203
Asymptomatic Chronic Elevation of Serum Pancreatic Enzymes: How to Deal with It? 198
The 1st i-EUS consensus on the management of pancreatic fluid collections – Part 2 197
Genetic and non-genetic risk factors for early-onset pancreatic cancer 189
3D Primary Cell Culture: A Novel Preclinical Model For Pancreatic Neuroendocrine Tumors (PanNETs) 189
EUS-guided GastroEnterostomy for management of malignant Gastric Outlet Obstruction: a prospective cohort study with matched comparison with Enteral Stenting 178
DIAGNOSTIC ACCURACY OF ENDOSCOPIC ULTRASOUND-FINE NEEDLE ASPIRATION (EUS-FNA) IN THE EVALUATION OF PANCREATIC NEUROENDOCRINE NEOPLASMS (PNEN) GRADING 168
Association of Smoking with progression from low-risk to high-risk intraductal papillary mucinous neoplasms and pancreatic cancer 160
International external validation of a stratification tool to identify branch-duct intraductal papillary mucinous neoplasms at lowest risk of progression 158
A polymorphic variant in telomere maintenance is associated with worrisome features and high-risk stigmata development in IPMNs 156
Communication, understanding and engagement of patients with pancreatic cancer at time of diagnosis 155
Reliability of grading preoperative pancreatic neuroendocrine tumors on EUS specimens: a systematic review with meta-analysis of aggregate and individual data 150
A four-step method to centralize pancreatic surgery, accounting for volume, performance and access to care 150
Role of pancreatic ductal adenocarcinoma risk factors in intraductal papillary mucinous neoplasm progression 149
A scan of all coding region variants of the human genome, identifies 13q12.2-rs9579139 and 15q24.1-rs2277598 as novel risk loci for pancreatic ductal adenocarcinoma 149
An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer 148
A tug-of-war in intraductal papillary mucinous neoplasms management: Comparison between 2017 International and 2018 European guidelines 147
A genome-wide association study identifies eight loci associated with intraductal papillary mucinous neoplasm progression toward malignancy 145
DIAGNOSTIC DELAY AT DIAGNOSIS AND TIME-TO-TREATMENT INFLUENCE OVERALL SURVIVAL OF PANCREATIC CANCER PATIENTS 142
Associations between pancreatic expression quantitative traits and risk of pancreatic ductal adenocarcinoma 142
Needle-Tract Seeding of Pancreatic Cancer after EUS-FNA: A Systematic Review of Case Reports and Discussion of Management 140
Incidence of endocrine and exocrine insufficiency in patients with autoimmune pancreatitis at diagnosis and after treatment: a systematic review and meta-analysis 138
Outcomes of a 3-Year Prospective Surveillance in Individuals at High Risk of Pancreatic Cancer 138
Intraductal Papillary Mucinous Neoplasms in High-Risk Individuals: Incidence, Growth Rate, and Malignancy Risk 134
Association of autoimmune pancreatitis and intraductal papillary mucinous neoplasm. A retrospective analysis from a tertiary care referral center 134
Efficacy and safety of rituximab for IgG4-related pancreato-biliary disease: A systematic review and meta-analysis 134
Glucose and lactate levels are lower in EUS-aspirated cyst fluid of mucinous vs non-mucinous pancreatic cystic lesions 133
Common variability in oestrogen-related genes and pancreatic ductal adenocarcinoma risk in women. 132
Advanced Digestive Neuroendocrine Tumors Metastatic Pattern Is an Independent Factor Affecting Clinical Outcome 132
Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer Risk 132
Diagnosis and treatment of exocrine pancreatic insufficiency in chronic pancreatitis: An international expert survey and case vignette study 131
Managing complications of chronic pancreatitis: a guide for the gastroenterologist 130
The prevalence of pancreatic cystic lesions in patients with liver cirrhosis is double that in controls 127
The role of biliary events in treatment and survival of patients with advanced pancreatic ductal adenocarcinoma 127
Ex-vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy 126
Surveillance of Individuals at High Risk of Developing Pancreatic Cancer: A Prevalence Meta-analysis to Estimate the Rate of Low-yield Surgery 125
Urgent manifestations of immunoglobulin G4-related disease 125
Factors Associated With the Risk of Progression of Low-Risk Branch-Duct Intraductal Papillary Mucinous Neoplasms 124
Personalized surveillance intervals for intraductal papillary mucinous neoplasm (IPMN): multicenter study using parametric models 123
Multicentric Italian survey on daily practice for autoimmune pancreatitis: Clinical data, diagnosis, treatment, and evolution toward pancreatic insufficiency 122
Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes 121
Italian Chronic Pancreatitis Registry (ITARECIPE): Protocol for a nationwide cohort study 117
Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study 116
Diagnostic accuracy of EUS-FNA in the evaluation of pancreatic neuroendocrine neoplasms grading: Possible clinical impact of misclassification 116
Differential EUS findings in focal type 1 autoimmune pancreatitis and pancreatic cancer: A proof-of-concept study 116
The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years’ experience of association studies to understand the genetic architecture of pancreatic cancer 116
Active surveillance beyond 5 years is required for presumed branch-duct intraductal papillary mucinous neoplasms undergoing non-operative management 116
Early onset pancreatic cancer. Risk factors, presentation and outcome 114
Polymorphisms in transcription factor binding sites and enhancer regions and pancreatic ductal adenocarcinoma risk 113
Chronic use of statins and acetylsalicylic acid and incidence of post-endoscopic retrograde cholangiopancreatography acute pancreatitis: A multicenter, prospective, cohort study 113
COMMUNI.CARE (COMMUNIcation and Patient Engagement at Diagnosis of PAncreatic CAncer): Study Protocol 113
Epidemiology, clinical features and diagnostic work-up of cystic neoplasms of the pancreas: Interim analysis of the prospective PANCY survey 112
Efficacy of endoscopic ultrasound-guided ablation with the hybridtherm probe in locally advanced or borderline resectable pancreatic cancer: A phase ii randomized controlled trial 112
The EFFect of dietary fat content on the recurrence of pancreaTitis (EFFORT): Protocol of a multicenter randomized controlled trial: Protocol of the EFFORT randomized trial: dietary fat reduction and pancreatitis recurrence 111
Preoperative assessment of microvessel density in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs) 111
RNA Extraction from Endoscopic Ultrasound-Acquired Tissue of Pancreatic Cancer Is Feasible and Allows Investigation of Molecular Features 111
EUS-guided gallbladder drainage and subsequent peroral endoscopic cholecystolithotomy: A tool to reduce chemotherapy discontinuation in neoplastic patients? 110
Systematic review and meta-analysis: Prevalence of incidentally detected pancreatic cystic lesions in asymptomatic individuals 110
Utility of the “2019 ACR/EULAR classification criteria” for the management of patients with IgG4-related disease 109
Predicting the need for step-up after EUS-guided drainage of peripancreatic fluid collections, including Quadrant-Necrosis-Infection score validation: A prospective cohort study 109
ENDOSCOPIC ULTRASOUND (EUS)-GUIDED RADIOFREQUENCY ABLATION (RFA) OF A SYMPTOMATIC PANCREATIC INSULINOMA 109
Alcohol and gastrointestinal cancers 107
ENDOSCOPIC ULTRASOUND-GUIDED HYBRID THERM ABLATION (EUS-HTP) IN PATIENTS (PTS) WITH LOCALLY ADVANCED (LA) PANCREATIC DUCTAL ADENOCARCINOMA (PDAC): A CASE-CONTROL COMPARATIVE SURVIVAL ANALYSIS 107
The i-EUS consensus on the management of pancreatic fluid collections – Part 1 106
Consensus guidelines on severe acute pancreatitis 106
Italian registry of families at risk of pancreatic cancer: AISP Familial Pancreatic Cancer Study Group 105
4. Smoking, alcohol and family history of cancer as risk factors for small intestinal neuroendocrine tumors: a systematic review and meta-analysis 105
Risk factors for the occurrence of ampullary tumors: A case-control study 104
Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patients 103
Activation of MNK2/eIF4E Pathway by the Splicing Factor SRSF1 Supports Pancreatic Cancer Cell Survival to Genotoxic Stress 102
Accuracy of TNM staging system in prognostic siratification of stage IV digestive endocrine tumors 101
Chronic use of statins and aminosalicylic acid and incidence of post-ERCP acute pancreatitis. Preliminary data from the STARK study, a prospective international, multicenter, cohort study 101
Hungarian Pancreatic Study Group. Antibiotic therapy in acute pancreatitis: From global overuse to evidence based recommendations 101
Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction 100
High sensitivity of ROSE-supported ERCP-guided brushing for biliary strictures 100
Pancreatic Neuroendocrine Neoplasms: Classification and Novel Role of Endoscopic Ultrasound in Diagnosis and Treatment Personalization 99
ACUTE PANCREATITIS PATIENT REGISTRY TO EXAMINE NOVEL THERAPIES IN CLINICAL EXPERIENCE (APPRENTICE): AN INTERNATIONAL MULTICENTER CONSORTIUM FOR THE STUDY OF ACUTE PANCREATITIS 99
European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations. 98
EUS-GUIDED GASTROENTEROSTOMY FOR MANAGEMENT OF MALIGNANT GASTRIC OUTLET OBSTRUCTION: A PROSPECTIVE SERIES FROM THE PROTECT REGISTRY 97
The impact of nutritional status on pancreatic cancer therapy 97
Pancreatic resections for benign intraductal papillary mucinous neoplasms: Collateral damages from friendly fire 97
Necrosis volume and Choi criteria predict the response to endoscopic ultrasonography-guided HybridTherm ablation of locally advanced pancreatic cancer 97
Common features between neoplastic and preneoplastic lesions of the biliary tract and the pancreas 96
A Case of Pancreatic Small Cell Neuroendocrine Carcinoma Associated With SIADH 95
Acute leukaemia following low dose peptide receptor radionuclide therapy for an intestinal carcinoid 95
Polymorphic variants involved in methylation regulation: a strategy to discover risk loci for pancreatic ductal adenocarcinoma 95
Effect of aspirin, ACE inhibitors/sartans and statins use on the progression of BD-IPMN in follow up: a multicenter study 95
EUS-guided ablation with the HybridTherm Probe as second-line treatment in patients with locally advanced pancreatic ductal adenocarcinoma: A case-control study 94
Targeting inflammation to prevent severe acute pancreatitis: NSAIDs are not the holy grail 94
Identification of patients with branch-duct intraductal papillary mucinous neoplasm and very low risk of cancer: multicentre study 94
ACCURACY OF THE NOVEL TNM STAGING SYSTEM IN THE PROGNOSTIC STRATIFICATION OF PATIENTS WITH ADVANCED STAGE. IV DIGESTIVE ENDOCRINE. TUMORS 91
Addendum 90
Feasibility of therapeutic endoscopic ultrasound in the bridge-to-surgery scenario: The example of pancreatic adenocarcinoma 90
Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment 90
Advanced Digestive Endocrine Tumors: Prognostic Factors Analysis and Patients Stratification According to Metastatic Status 89
Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer. 89
Exocrine pancreatic insufficiency in diabetic patients. prevalence, mechanisms, and treatment 88
The Italian registry of families at risk for pancreatic cancer (IRFARPC): implementation and evolution of a national program for pancreatic cancer surveillance in high-risk individuals 88
Totale 12.280
Salva come PNG Salva come JPEG
Categoria #
all - tutte 145.068
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 145.068
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202268 0 0 0 29 9 2 4 3 10 3 2 6
2022/2023642 196 114 47 1 10 80 78 63 30 2 12 9
2023/20241.058 48 36 81 256 70 149 46 111 18 29 65 149
2024/20254.788 512 138 88 131 300 460 557 385 880 600 349 388
2025/202616.469 1.165 1.174 986 1.939 1.208 528 1.518 1.137 4.544 1.122 599 549
2026/20275.017 615 1.362 1.007 2.033 0 0 0 0 0 0 0 0
Totale 28.128